NCT00193661View on ClinicalTrials.gov

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2002

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Primary or Secondary HypogonadismConstitutional Delay in Growth and Puberty (CDGP)
Interventions
DRUG

Testosterone Gel (1%)

Trial Locations (19)

Unknown

Site 130, Birmingham

Site 107, Los Angeles

Site 113, Sacramento

Site 114, Torrance

Site 121, Gainesville

Site 127, Jacksonville

Site 128, Jacksonville

Site 117, Indianapolis

Site 111, Kansas City

Site 129, Brooklyn

Site 123, New York

Site 131, Cincinnati

Site 124, Columbus

Site 103, Portland

Site 109, Hershey

Site 125, Philadelphia

Site 126, Philadelphia

Site 104, Memphis

Site 205, Seattle

All Listed Sponsors
collaborator

Unimed Pharmaceuticals

INDUSTRY

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00193661 - Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism | Biotech Hunter | Biotech Hunter